Baird Medical Investment (NASDAQ:BDMD) and Autonomix Medical (NASDAQ:AMIX) Head-To-Head Survey

Autonomix Medical (NASDAQ:AMIX) and Baird Medical Investment (NASDAQ:BDMD) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, profitability, institutional ownership and valuation.

Institutional & Insider Ownership

10.8% of Autonomix Medical shares are held by institutional investors. Comparatively, 19.8% of Baird Medical Investment shares are held by institutional investors. 6.2% of Autonomix Medical shares are held by insiders. Comparatively, 78.9% of Baird Medical Investment shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Autonomix Medical and Baird Medical Investment, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Autonomix Medical	1	1	1	0	2.00
Baird Medical Investment	1	0	0	0	1.00

Autonomix Medical currently has a consensus price target of $5.00, suggesting a potential upside of 587.76%. Given Autonomix Medical’s stronger consensus rating and higher possible upside, analysts plainly believe Autonomix Medical is more favorable than Baird Medical Investment.

Profitability

This table compares Autonomix Medical and Baird Medical Investment’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Autonomix Medical	N/A	-201.60%	-162.81%
Baird Medical Investment	N/A	N/A	N/A

Volatility & Risk

Autonomix Medical has a beta of -2.76, meaning that its share price is 376% less volatile than the S&P 500. Comparatively, Baird Medical Investment has a beta of -1.06, meaning that its share price is 206% less volatile than the S&P 500.

Valuation & Earnings

This table compares Autonomix Medical and Baird Medical Investment”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Autonomix Medical	N/A	N/A	-$11.41 million	($5.74)	-0.13
Baird Medical Investment	$37.04 million	1.23	N/A	N/A	N/A

Baird Medical Investment has higher revenue and earnings than Autonomix Medical.

Summary

Baird Medical Investment beats Autonomix Medical on 6 of the 9 factors compared between the two stocks.

About Autonomix Medical

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.

About Baird Medical Investment

Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.